Find Academic Supervisors

Fadia KamalView profile

Associate Professor

• Osteoarthritis Research
• Chondrocyte Biology
• Cartilage Homeostasis
• +5 more

Fadia Kamal, PharmD, PhD is an Associate Professor holding dual appointments in the Department of Orthopaedics and Rehabilitation and the Department of Cell and Biological Systems. She leads research at the Center for Cannabis and Natural Product Pharmaceuticals (CCNPP) with a strong publication record including 33 research outputs and an h-index of 18 based on Scopus data. Dr. Kamal's research focuses on cellular pathways that control chondrocyte homeostasis in healthy tissue and the pathological processes leading to cartilage damage in osteoarthritis. Her work investigates how chondrocytes transform into pathological cells that cause cartilage degradation, with particular interest in discovering new pathways and drugs to control chondrocyte behavior and potentially reverse osteoarthritis progression. Her laboratory also explores the therapeutic potential of non-euphorigenic cannabis compounds for bone fracture pain management and healing. Her recent publications demonstrate a strong trend toward interdisciplinary research combining orthopedics, molecular biology, immunology, and pharmacology. The work spans from fundamental cellular mechanisms in osteoarthritis to applied therapeutic development, with particular emphasis on cannabis-based treatments, immune responses in fracture healing, and novel imaging techniques. Her research shows increasing collaboration across multiple institutions and disciplines. Scientific Awards: Samuel Hinkle Junior Faculty Research Scholar Award (2022) - widely recognized with coverage by 5 news outlets, blogged by 1 source, posted by 38 X users, and shared on 1 Facebook page with 33 Mendeley readers Dr. Kamal serves as Principal Investigator on significant research projects, most notably the NIH-funded 'Therapeutic targeting of GPCR Gbetagamma-GRK2 in osteoarthritis' project (2019-2023) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Her mentorship is evident through numerous co-authored publications with junior researchers who appear to be her students and postdoctoral fellows. She maintains active collaborations across immunology, bone healing, and natural product pharmacology research areas. Her work contributes to UN Sustainable Development Goals related to health and well-being, with research spanning osteoarthritis, heart failure progression, chondrocyte biology, and G protein-coupled receptor research. The Kamal lab maintains strong connections with the Center for Cannabis and Natural Product Pharmaceuticals, indicating a specialized research focus on natural compounds for musculoskeletal conditions.

Tos T.J.M. BerendschotView profile

Researcher

• Biomedical Engineering
• Medical Image Analysis
• Diabetes Research
• +4 more

Tos T.J.M. Berendschot is a University Researcher in Biomedical Engineering at Eindhoven University of Technology , specializing in Medical Image Analysis . His work spans interdisciplinary domains linking diabetes, neurodegeneration, and ophthalmology. Email: t.t.j.m.berendschot@tue.nl Research Interests focus on diabetic complications, retinal neurodegeneration, and AI-driven medical imaging. Key areas include: Maturity Onset Diabetes of the Young (MODY) Microvascular dysfunction Advanced Glycation End-Products (AGEs) Retinal vascular tree analysis Keratoconus detection via AI Optical Coherence Tomography (OCT) Selected Publications highlight AI applications in ophthalmology, diabetic neurodegeneration, and vascular connectivity studies. Collaborations include Maastricht University Medical Center and international conferences in computer vision. Media Contributions feature expert commentary on cataract surgery, keratoconus, Alzheimer's disease biomarkers, and intraocular lens calculations.

Matthias FeigeView profile

Associate Professor

• Protein Biochemistry
• Cell Biology
• Immunology
• +3 more

Matthias Feige is an Associate Professor of Cellular Protein Biochemistry at the Technical University of Munich (TUM). He leads the Focus Group for Cellular Protein Biochemistry, previously serving as a Rudolf Mößbauer Tenure Track Assistant Professor. His research focuses on understanding cellular proteome integrity, particularly in the secretory pathway, combining protein biochemistry and cell biology. Key interests include protein folding, quality control mechanisms, and their biomedical applications. Education & Career: PhD in Biochemistry (2009), TUM under Johannes Buchner Postdoctoral Fellowship at St. Jude Children’s Research Hospital (Memphis, USA) with Linda Hendershot Head of the Cellular Protein Biochemistry Lab at TUM since 2015 Research Interests: Feige’s work explores molecular mechanisms governing protein biogenesis, secretory pathway proteins, and their roles in immunity. His interdisciplinary approach targets fundamental biology and translational applications like protein engineering and therapy development. Scientific Contributions: His publications highlight advancements in cytokine assembly, ER quality control, and protein aggregation mechanisms. Notable recent work includes studies on KDELR3 signaling, helminth immune modulation, and engineered cytokines. Awards & Recognition: Leopoldina Fellowship (2011–2014) Fellow of the Daimler and Benz Foundation (2016) Rainer Rudolph Award (2012) Multiple honors from TUM and international institutions Labs & Teams: He directs a lab investigating protein biogenesis and proteostasis. Collaborations span biochemistry, immunology, and structural biology, with a focus on translational research.

Shalini PrasadView profile

Professor

• Bioengineering
• Nanotechnology
• Medical Diagnostics
• +3 more

Dr. Shalini Prasad is the Cecil H. and Ida Green Professor in Systems Biology Science and Associate Professor of Bioengineering at the University of Texas at Dallas (UT Dallas), affiliated with the Erik Jonsson School of Engineering and Computer Science. She also holds an adjunct professorship in Physics at Portland State University. Her research focuses on developing nanomaterial-based biosensors for medical diagnostics, environmental monitoring, and public health applications. She leads the Biomedical Microdevices and Nanotechnology Lab, which has supported over 50 researchers across graduate and undergraduate levels. Dr. Prasad earned her PhD in Electrical Engineering from the University of California, Riverside (2004) and B.E. in Electronics and Communication Engineering from the University of Madras (2000). Her career includes roles at Portland State University, Arizona State University, and Wichita State University. She has received prestigious awards, including the Bomhoff Distinguished Professorship and the Cecil Green Professorship, and holds over 30 peer-reviewed publications. Her research interests emphasize interdisciplinary approaches to create affordable, portable diagnostic tools for diseases like cancer, neurodegeneration, and cardiovascular disorders, as well as environmental sensors for soil health and water quality. Recent work includes wearable devices for monitoring inflammatory bowel disease and asthma, saliva-based THC detection, and low-cost CO₂/humidity sensors. Awards: Graduate Student Research Award (2004) Bomhoff Distinguished Professor of Bioengineering Cecil H. and Ida Green Professorship Advising & Grants: Dr. Prasad’s lab has secured funding from federal agencies and corporate partners, supporting projects like the SWEAT wearable for chronic inflammation tracking and soil health sensors. Her work bridges engineering, biology, and clinical applications, with a focus on translational technologies. Labs/Teams: Director of the Biomedical Microdevices and Nanotechnology Lab, collaborating on interdisciplinary projects with industry and academic partners.

Cornelius FaberView profile

Professor

• MRI cell tracking
• infection imaging
• MR methodology
• +6 more

Cornelius Faber is a University Professor in the Department of Radiology at the University of Münster, Germany, where he leads the Experimental Nuclear Magnetic Resonance research group. His work focuses on developing and implementing novel MRI techniques that extend the boundaries of magnetic resonance imaging in terms of spatial and temporal resolution, sensitivity, and specificity for physiological, structural, and molecular changes. He actively participates in the "Cells in Motion" interdisciplinary research initiative at the university. Professor Faber's research spans multiple critical areas in medical imaging and biomedical science. His primary expertise lies in MRI cell tracking , enabling visualization of cellular dynamics in vivo. He has made significant contributions to infection imaging , developing methods to detect and characterize microbial infections using MRI. His work on MR methodology development has advanced quantitative imaging techniques, while his research on multimodal integration in MR and MRI contrast mechanisms has provided deeper insights into molecular and cellular processes. His research bridges physics, engineering, and biomedical applications, with particular relevance to inflammation, cancer, neurological disorders, and cardiovascular disease. Analysis of Professor Faber's extensive publication record reveals a clear evolution from fundamental MRI technique development toward increasingly sophisticated applications in disease models. His recent work demonstrates a strong trend toward multimodal imaging approaches that combine MRI with complementary techniques such as mass spectrometry, optical imaging, and PET. This integration creates comprehensive diagnostic platforms that provide both anatomical and molecular information. A notable pattern is the focus on cellular dynamics, particularly immune cell behavior in inflammatory conditions and tumor microenvironments, with applications spanning neuroscience, oncology, and cardiology. Professor Faber leads a multidisciplinary research team of approximately 15 members, including scientists, doctoral students, technicians, and medical students. His laboratory is deeply integrated with the University of Münster's research infrastructure, particularly the Multiscale Imaging Centre. The group's work contributes significantly to advancing preclinical MRI methodologies while maintaining strong clinical relevance, with numerous publications in high-impact journals across medical imaging, neuroscience, and biomedical engineering disciplines.

• Biomaterials
• Biomechanics
• Bone Tissue Engineering
• +3 more

Amy Wagoner Johnson is a Professor in the Department of Biomedical and Translational Sciences at the Carle Illinois College of Medicine, University of Illinois Urbana-Champaign, with secondary appointments in Mechanical Science and Engineering. She leads the Applied Biomaterials and Biomechanics Lab (ABBL), conducting interdisciplinary research spanning bone tissue engineering, women's reproductive health, and coral reef restoration. Her educational background includes: Ph.D. in Materials Science from Brown University (2002) M.S. in Materials Science from Brown University (1998) B.S. in Materials Science and Engineering from The Ohio State University (1996) Professor Wagoner Johnson's research focuses on biomaterials and biomechanics, particularly: Developing multiscale bone scaffolds for trauma repair Investigating cervical biomechanics in pregnancy and preterm birth Creating coral settlement substrates for reef restoration Designing hydroxyapatite-based systems for stem cell delivery Her work integrates materials science, mechanical engineering, and clinical medicine to address critical challenges in tissue regeneration. Analysis of her recent publications reveals strong trends in translational biomaterials development, with increasing emphasis on women's health applications and marine ecosystem restoration. Her bone scaffold research has evolved toward multi-material systems with spatially graded architectures, while her reproductive health work increasingly employs advanced imaging techniques like second-harmonic generation microscopy. Her scientific honors include: Fellow of the American Institute for Medical and Biological Engineering (2021) Grainger College DEI Award (2022) Andersen Faculty Scholar (2020) Dean's Research Excellence Award (2018) As an educator, she has received multiple teaching awards including the Society of Women Engineers Outstanding Engineering Educator Award (2020) and multiple 'Teachers Ranked as Excellent' recognitions. She serves as MechSE Pre-Med Advisor and actively mentors undergraduate researchers, receiving the Campus Award for Guiding Undergraduate Research (2013). Her lab has secured significant funding for projects including NSF's 'Collaborative Research: ECO-CBET' and NIH-supported work on preterm birth mechanisms. The Applied Biomaterials and Biomechanics Lab maintains strong collaborations with veterinary medicine, surgery departments, and international partners including the NanoSciences Foundation in Grenoble, France. Current projects focus on developing tools to track inflammation in human tissue as Chan Zuckerberg Biohub Chicago Investigators.

Allan B. DietzView profile

Professor

• Cellular Immunotherapy
• Stem Cell Biology
• Cancer Vaccines
• +5 more

Allan B. Dietz is a Professor of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine and Science. He serves as Co-Director of the Human Cellular Therapy Lab at Mayo Clinic's Center for Regenerative Biotherapeutics, with dual appointments in the Department of Immunology and Division of Transfusion Medicine. 1986: BA in Biology and Chemistry from University of Northern Iowa 1992: PhD in Genetics from Texas A&M University 1993: Postdoctoral Fellowship at USDA Agricultural Research Service His research spans cellular immunotherapy, stem cell biology, and regenerative medicine , with a focus on dendritic cell vaccines for cancers (CML, melanoma, glioblastoma), monocyte immunosuppression mechanisms, and mesenchymal stromal cell applications in GVHD and tissue repair (ALS, Crohn’s, renal stenosis, diabetes). Recent work includes microfluidic bioreactor development for cell therapy manufacturing and immune profiling for cancer patients. Key publications from 2024-2025 include: Microfluidic bioreactors for dendritic cell production Pembrolizumab-ibrutinib melanoma trials Mesenchymal stem cells in spinal cord injury Multiorgan transplant immune management guidelines Awarded: 2017 Mayo Clinic Team Science Award 1997 Voyles Fellowship in Stem Cell Biology 1991 Carrington Award for Cell Biology Active in regulatory committees including FDA-compliant cell therapy oversight and ISCT North American meetings. Integrates laboratory findings with clinical workflows through Mayo Clinic's CCaTS and Center for Individualized Medicine programs.

• Immunology
• Biochemistry and Cell Biology
• Clinical Sciences
• +3 more

Professor Daniel Davis MBE FMedSci is the Head of the Department of Life Sciences and Professor of Immunology at Imperial College London. He holds affiliations with the Institute of Chemical Biology, the CDT in Chemical Biology: Innovation in Life Sciences (as a supervisor), and research groups in Immunology and Molecular Mechanisms of Disease. His academic journey includes a doctorate in Physics from Harvard University and prior roles as Director of Research at the Manchester Collaborative Centre for Inflammation Research (University of Manchester). His research focuses on nanoscale biology of immune cell interactions, employing advanced microscopy techniques to study immune synapse formation, cytotoxicity mechanisms, and immunological regulation. Notable contributions include elucidating how immune cells use adhesion, signaling, and structural reorganization to target pathogens and cancer cells. Professor Davis has authored four popular science books, including Self Defence: A Myth-Busting Guide to Immune Health (2025), The Beautiful Cure (2018), and The Compatibility Gene (2014), which bridge public understanding of immunology and biology. His work has been recognized with prestigious awards such as the Royal Society Science Book Prize and the Prose Award. His articles span topics like NK cell heterogeneity, gene therapy for neurological disorders, and super-resolution microscopy applications. Grants and collaborations include work on AAV-based gene therapies and immunomodulatory drug development. Davis actively engages in public science communication through festivals, media outlets (e.g., BBC, Guardian), and international speaking engagements. His research labs at Imperial College focus on interdisciplinary approaches, combining biophysics, genetics, and clinical applications to advance immunology and translational medicine.

Ai-ris Yonekura CollierView profile

Assistant Professor

• Maternal-Fetal Medicine
• Immunology in Pregnancy
• Infectious Diseases in Pregnancy
• +3 more

Dr. Ai-ris Yonekura Collier serves as Assistant Professor in Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School and Staff Physician in the Department of Obstetrics and Gynecology at Beth Israel Deaconess Medical Center (BIDMC). She concurrently holds a Physician-Scientist position at BIDMC's Center for Virology and Vaccine Research (CVVR) and co-directs the Clinical Trials Unit within CVVR, establishing a critical bridge between maternal-fetal medicine and virology research. Her academic foundation includes: B.S. in Biology (Minor: Chemistry) from Massachusetts Institute of Technology (2005) M.D. from Harvard Medical School through Harvard-MIT Health Sciences & Technology Program (2011) Obstetrics & Gynecology Residency at UCLA (2011-2015) Maternal-Fetal Medicine Fellowship at BIDMC (2015-2018) Dr. Collier's research centers on maternal immune tolerance mechanisms in placental development, with dual investigative tracks: (1) Characterizing cellular immune phenotypes in pregnancy disorders like preeclampsia and fetal growth restriction, and (2) Analyzing infectious disease impacts including Zika virus and SARS-CoV-2. Her translational approach integrates longitudinal biospecimen repositories with clinical observations, emphasizing the inclusion of pregnant populations in vaccine trials. As an educator, she actively mentors trainees and advocates for policy changes in clinical trial design. Recent publications demonstrate a pronounced focus on viral immunology during the pandemic era, with 7 of 9 recent papers addressing SARS-CoV-2 variants, vaccine responses, and Mpox immunity. These works reveal consistent methodological themes: neutralization assays against emerging variants, analysis of coagulation-inflammation pathways in vaccine complications, and sensitive diagnostic approaches for prior infections. Concurrently, she maintains her foundational research in placental immunology, exemplified by cytokine studies in preeclampsia. Her scientific recognition includes: NIH Loan Repayment Program (2018-2020) Mentor Award from ACOG District I (2021) Translational Research Hubs Spark Grant Award (2022) Rookie of the Year Award at BIDMC (2016) Multiple research presentation awards from perinatal societies As Principal Investigator of the Yonekura Collier Laboratory and Co-Director of the Clinical Trials Unit, she manages substantial grant funding including NIH/NICHD support and institutional translational grants. Her leadership extends to hospital-wide initiatives like the BIDMC COVID-19 Biorepository, while her advocacy focuses on rectifying historical exclusions of pregnant individuals from clinical research. She maintains active collaborations across Harvard's immunology and virology departments. The Yonekura Collier Laboratory operates within CVVR's collaborative ecosystem, integrating with Dan Barouch's research group and the broader Harvard Medical School community. Her team combines clinical obstetric expertise with advanced immunological techniques to investigate fetal-maternal interface biology, creating a unique interdisciplinary hub for perinatal infectious disease research.

Daniel R ObaidView profile

Associate Clinical Professor

• Interventional Cardiology
• Cardiac Computed Tomography
• Intravascular Imaging
• +5 more

Dr. Daniel R Obaid is a Clinical Associate Professor and Consultant Cardiologist at Swansea University Medical School , specializing in Biomedical Sciences . His clinical academic work at the Morriston Regional Cardiac Centre and ILS 2 Clinical Imaging Facility focuses on advanced cardiovascular imaging and interventional cardiology. Expertise in Interventional Cardiology , Cardiac CT , and Atherosclerotic Plaque Imaging Significant contributions to patient safety and human factors in cardiovascular procedures Recipient of the Young Investigator Prize from the Society of Cardiovascular CT, USA His research integrates invasive and non-invasive imaging techniques to identify vulnerable plaques, with publications spanning atherosclerosis , clot microstructure , and AI applications in cardiology . Current studies include virtual TAVR simulations and biomechanical analysis of plaque stress . Recent collaborative work explores low-dose radiation protocols , LDL transport modeling , and anti-inflammatory effects of GLP-1 agonists , reflecting interdisciplinary approaches to cardiovascular risk mitigation. Available for postgraduate supervision , Dr. Obaid has contributed to undergraduate medical professionalism and cardiovascular physiology modules (PM-241F, PM-266).

• Stem Cell Research
• Orthopedics
• Sports Medicine
• +5 more

Dr. Sohrab Khatab is a Researcher in the Department of Orthopedics and Sports Medicine at Erasmus MC, a leading medical center affiliated with Erasmus University Rotterdam. His work focuses on innovative treatments for joint disorders, particularly using stem cell therapies and regenerative medicine approaches. Dr. Khatab's research spans multiple disciplines including orthopedics, veterinary science, and regenerative medicine. His primary interests include stem cell research, arthritis treatment, intra-articular therapies, and osteoarthritis management. His work utilizes various animal models including equine, murine, and in vitro systems to develop novel treatments for joint inflammation and cartilage damage. Analysis of Dr. Khatab's publications reveals a consistent focus on regenerative approaches for joint disorders. His research demonstrates expertise in stem cell secretome applications, platelet-rich plasma therapies, and biomaterial encapsulation techniques. The work shows progression from basic in vitro studies to more complex animal models, indicating translational research aimed at clinical applications in orthopedics and sports medicine. Dr. Khatab has collaborated extensively with researchers at Erasmus MC, particularly with G. van Osch, N. Kops, K. Bos, and J. Verhaar. His work has generated significant academic interest with multiple publications accumulating substantial citations in the field of orthopedic regenerative medicine. Dr. Khatab's research is conducted within the Orthopedics and Sports Medicine department at Erasmus MC, which appears to have strong capabilities in regenerative medicine, stem cell research, and translational orthopedics. His work with both equine and murine models suggests access to comprehensive laboratory facilities for preclinical testing of novel orthopedic treatments.

Sven HermannView profile

Senior Lecturer

• Molecular Imaging
• Immunology
• Infectious Diseases
• +3 more

Sven Hermann is a Senior Lecturer at the European Institute for Molecular Imaging (EIMI) within the University of Münster, leading the Preclinical Imaging Group. His research focuses on developing molecular imaging strategies for inflammation and infection, including PET, SPECT, fluorescence reflectance imaging, and optoacoustic imaging. Key targets include matrix metalloproteinases (MMPs) and alarmins (S100A8/S100A9), with applications in cardiovascular diseases, rheumatoid arthritis, and bacterial imaging. He participates in the Cells in Motion Cluster of Excellence and leads DFG-funded projects TRR332-C07 and CRC1450-C03, investigating immune regulation and imaging techniques. Affiliations: EIMI, University of Münster; Core Unit Pix (preclinical imaging). Research Themes: Bacterial imaging via maltodextrin transporters, MMP activity visualization in atherosclerosis, and S100A8/A9-driven immune modulation. His work integrates engineering and biology to translate imaging innovations into clinical applications, emphasizing multimodal approaches for disease monitoring.

• Liver Disease
• Alcohol-Related Liver Disease
• Liver Fibrosis
• +7 more

Camilla Dalby Hansen is a researcher at the Department of Clinical Research, University of Southern Denmark, affiliated with Odense University Hospital (OUH) and the FLASH - Centre for Liver Research in Odense. Her work focuses on liver diseases, particularly metabolic and alcohol-related disorders, with a strong emphasis on biomarker development and fibrosis assessment. University: University of Southern Denmark Faculty: Faculty of Health Sciences Department: Department of Clinical Research Research Centre: FLASH - Centre for Liver Research (Odense) Collaborations: Odense University Hospital (OUH), KI Her research interests center on liver disease, alcohol-related liver disease, liver fibrosis, nonalcoholic fatty liver disease (NAFLD/MASLD), biomarkers, and prospective cohort studies. She investigates metabolic dysfunction-associated steatotic liver disease (MASLD), fibrosis progression, and the accuracy of diagnostic tools such as self-reported alcohol intake versus phosphatidylethanol biomarkers. Her work integrates clinical data, biomarker validation, and risk prediction models for early detection and management of liver disease. Camilla Dalby Hansen's recent publications (2025) in journals like The Lancet Gastroenterology & Hepatology and Journal of Hepatology reflect a research trajectory focused on improving early diagnosis and prognostic tools for liver fibrosis. Her studies often employ prospective cohort designs and involve dual biopsy validation, biomarker performance evaluation, and community-based prevalence assessments. Themes include the development of LiverPRO for primary care, discrepancies in alcohol reporting, and the role of novel biomarkers like soluble TREM2 and PRO-C3 in tracking disease activity. She has not received any publicly listed scientific awards or fellowships in the provided text. Camilla Dalby Hansen has contributed to research projects as a co-author and collaborator, particularly in dietary interventions for type 2 diabetes and liver disease. While no formal students are listed, her role in large-scale studies suggests mentorship and collaborative supervision. She is involved in EU-funded projects like LIVERAIM, indicating participation in major translational research initiatives. Her email is cdhansen@health.sdu.dk. She is part of the FLASH - Centre for Liver Research, a multidisciplinary team focusing on liver disease mechanisms, diagnostics, and treatment. Her work aligns with clinical hepatology, metabolic research, and public health screening, contributing to both academic knowledge and practical clinical tools.

John AlbeckView profile

Professor

• Cell Signaling
• Signal Transduction
• Single-Cell Biology
• +7 more

John Albeck is a Professor in the Department of Molecular and Cellular Biology at the University of California, Davis, within the College of Biological Sciences. He leads the Albeck Lab, which is dedicated to understanding the dynamic behavior of signaling pathways such as ERK, Akt, AMPK, and mTOR in regulating cell growth, survival, and metabolism. His research combines live-cell imaging with computational modeling to decode how temporal signaling patterns determine cell fate decisions. He is affiliated with the Biochemistry, Molecular, Cellular and Developmental Biology (BMCDB) Graduate Group and actively mentors graduate students and postdoctoral researchers. Position: Professor Institution: University of California, Davis Department: Molecular and Cellular Biology Graduate Program: BMCDB Lab Website: albecklab.ucdavis.edu Education: B.A. in Biological Sciences, Cornell University, 2000 Ph.D. in Computational and Systems Biology, Massachusetts Institute of Technology, 2007 Dr. Albeck's research focuses on the information flow in signal transduction networks , particularly how dynamic activation patterns encode specificity in cellular responses. His lab uses genetically encoded fluorescent biosensors to track signaling events in real time across single cells, integrating this data with computational models to predict cellular behaviors. This approach addresses how a limited set of pathways can control diverse outcomes like proliferation, apoptosis, and autophagy. A major goal is to improve cancer therapies by predicting how cells respond to targeted inhibitors, especially in the context of heterogeneous and adaptive responses. His recent publications highlight work on ERK signaling dynamics , inflammatory responses in airway cells , and the development of biosensors for FGF and AMPK. These studies employ advanced techniques such as cyclic immunofluorescence (4i) , machine learning , and ordinary differential equation (ODE) modeling to infer signaling history from fixed-cell data. The lab also develops computational tools for data analysis, including automated cluster detection and spectral unmixing. Scientific Contributions and Trends: Deciphering how temporal patterns in ERK activity correlate with downstream gene expression (e.g., Fra-1, pRb, Egr-1) Modeling signaling dynamics to predict cell fate under therapeutic inhibition Investigating spatiotemporal signaling clusters in epithelial inflammation Developing Red-FRET biosensors for AMPK and ERK Exploring metabolic signaling and immune modulation by lactate Dr. Albeck advises a diverse group of graduate students and has trained several postdoctoral researchers who have gone on to careers in academia and biotechnology. His lab fosters a collaborative environment that bridges experimental biology and computational analysis. While no formal awards are listed in the provided text, his lab's recognition through publications in high-impact journals and integration into major research initiatives (e.g., UC Davis Lung Center T32 training) underscores his impact. The lab also supports research through internal grants and collaborative projects focused on cancer signaling and lung biology. Laboratory and Team: The Albeck Lab includes graduate students, postdoctoral researchers, and staff scientists working on projects ranging from biosensor development to single-cell data analysis. Current team members include Christi Abbate, Elijah Kofke, and Marion Hardy (graduate students), and staff such as Michael Pargett and Carolyn Teragawa. The lab emphasizes interdisciplinary training and open science, with code and methods shared via GitHub.

Emilia LimView profile

Assistant Professor

• Bioinformatics
• Cancer
• Aging
• +5 more

Dr. Emilia Lim is an Assistant Professor in the Department of Biochemistry and Molecular Biology at the University of British Columbia's Faculty of Medicine , with an investigator role at the Edwin S.H. Leong Centre for Healthy Aging . She specializes in computational analysis of environmental exposures, particularly pollution, in age-related diseases like cancer. Education: BSc from University of Alberta (2009) PhD from University of British Columbia (2016) Postdoctoral training at Francis Crick Research Institute, University College London (2023) Her research integrates multi-omic approaches (genomics, transcriptomics, epigenomics) to investigate how environmental pollutants drive disease states in samples like cancer patients. Recent work focuses on lung cancer evolution , immune evasion , and epigenetic aging under pollution exposure, with applications in precision oncology and healthy aging initiatives across Canada. Publications highlight her expertise in cancer genomics , environmental toxicology , and computational biology , with key contributions to understanding air pollution-induced carcinogenesis (2023) and subclonal tumor dynamics (2020, 2023). Her lab develops tools like SPRINTER for single-cell cancer evolution analysis and explores haplotype-specific copy number in tumor heterogeneity ( Refphase , 2023).